SUBLICENSE AGREEMENTSublicense Agreement • September 9th, 2015 • HedgePath Pharmaceuticals, Inc. • Services-commercial physical & biological research • Maryland
THIS SUBLICENSE AGREEMENT (the “Agreement”) is entered into effective as of the Effective Date by and between MAYNE PHARMA INTERNATIONAL PTY LTD, ABN 88 007 870 984, an Australian body corporate having an address at Level 14, 474 Flinders Street, Melbourne, VIC, 3000, Australia (“Mayne Pharma”), and HEDGEPATH PHARMACEUTICALS, INC, a company incorporated in Delaware having an address at 324 South Hyde Park Avenue #350, Tampa, Florida, 33606, United States (“HPPI”) with respect to the following:
